Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artesunate Monotherapy and DHA-PPQ for Uncomplicated Falciparum Malaria in Vietnam
NCT02604966Phase 4Unknown
- Sponsor
- National Institute of Malariology, Parasitology and Entomology
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of artesunate in Plasmodium falciparum malaria (2 arms), sponsored by National Institute of Malariology, Parasitology and Entomology. Primary endpoint: Median parasite clearance time at Day 42. Status: unknown.
02
Drugs
artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02604966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604966.